EVMed GROUP

English العربية
 ABOUT US
EVMed Group Biotechnology operates a state-of-the-art GMP-certified production facility spanning more then 3,000 square meters. The company has implemented a rigorous GLP and GMP-compliant quality management system to ensure the highest standards of production. With Suzhou headquarters, Shanghai Umibio branch and Shaoxing Youming manufacturing center, EVMed Group has developed a diversified business portfolio that includes pharmaceutical research and development, raw materials, finished dosage forms, and reagents, all centered around its core technology of exosome-based products.
Company History
  • 2015
  • 2016
  • 2017
  • 2019
  • 2021
  • 2022
  • 2023
  • 2024

Shanghai Umibio (the predecessor of EVMed) was established to advance research and innovation in exosome biotechnology as the first exosome biotech company in China 

Revenue from extracellular vesicle products exceeds $10 million

Shaoxing manufacturing center established

The major exosome research products provider in China taking more than 80% of the market share

Obtained first round of financial investment, with the highest company value in exosome industry in China

EVMed Suzhou headquarters established, with 3000m2 GMP-standard manufacturing facility

BSL-2 laboratory constructed. Obtained ISO9001, ISO14001, and ISO45001 system certifications. Launched China's first engineering project for Exosome GMP workshop

Expanding our global presence, transferring our technology internationally, leveraging innovative solutions to drive growth, and creating new opportunities worldwide

Suzhou headquarters
Shanghai branch
Shaoxing manufacturing center